Literature DB >> 19740320

Roles of proinflammatory cytokines and the Fas/Fas ligand interaction in the pathogenesis of inflammatory myopathies.

Masahiro Kondo1, Yohko Murakawa, Nanae Harashima, Shotai Kobayashi, Shuhei Yamaguchi, Mamoru Harada.   

Abstract

Within the lesions of inflammatory myopathies, muscle fibres and invading mononuclear cells express Fas and Fas ligand (FasL), respectively. However, the roles of the Fas/FasL interaction in the pathogenesis of inflammatory myopathies are not fully understood. In the present study, we investigated the roles of proinflammatory cytokines and the Fas/FasL system in the pathogenesis of inflammatory myopathies. In vitro culturing of muscle cells with the proinflammatory cytokines interferon-gamma, tumour necrosis factor-alpha, and interleukin (IL)-1beta synergistically increased Fas expression, susceptibility to Fas-mediated apoptosis, and the expression of cytoplasmic caspases 8 and 3. In addition, culturing of muscle cells with activated CD4(+) T cells induced muscle cell apoptosis, which was partially inhibited by anti-FasL antibody. We also tested the possibility that T helper (Th) 17, which is an IL-17-producing helper T-cell subset that plays crucial roles in autoimmune and inflammatory responses, participates in the pathogenesis of inflammatory myopathies. Interestingly, in vitro culturing of dendritic cells with anti-Fas immunoglobulin M (IgM) or activated CD4(+) T cells induced the expression of mRNA for IL-23p19, but not for IL-12p35, in addition to proinflammatory cytokines. Furthermore, IL-23p19 and IL-17 mRNAs were detected in the majority of biopsy samples from patients with inflammatory myopathies. Taken together, these results suggest that proinflammatory cytokines enhance Fas-mediated apoptosis of muscle cells, and that the Fas/FasL interaction between invading dendritic cells and CD4(+) T cells induces local production of IL-23 and proinflammatory cytokines, which can promote the proliferation of Th17 cells and enhance Fas-mediated apoptosis of muscle cells, respectively.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19740320      PMCID: PMC2753936          DOI: 10.1111/j.1365-2567.2008.03039.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  41 in total

Review 1.  Polymyositis and dermatomyositis (second of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-20       Impact factor: 91.245

2.  Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway.

Authors:  D Ashany; A Savir; N Bhardwaj; K B Elkon
Journal:  J Immunol       Date:  1999-11-15       Impact factor: 5.422

3.  The inhibition of apoptosis in myositis and in normal muscle cells.

Authors:  K Nagaraju; L Casciola-Rosen; A Rosen; C Thompson; L Loeffler; T Parker; C Danning; P J Rochon; J Gillespie; P Plotz
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

4.  Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12.

Authors:  B Oppmann; R Lesley; B Blom; J C Timans; Y Xu; B Hunte; F Vega; N Yu; J Wang; K Singh; F Zonin; E Vaisberg; T Churakova; M Liu; D Gorman; J Wagner; S Zurawski; Y Liu; J S Abrams; K W Moore; D Rennick; R de Waal-Malefyt; C Hannum; J F Bazan; R A Kastelein
Journal:  Immunity       Date:  2000-11       Impact factor: 31.745

5.  Immunolocalization of FAS and FAS ligand in inflammatory myopathies.

Authors:  J L De Bleecker; V I Meire; I E Van Walleghem; I M Groessens; J M Schröder
Journal:  Acta Neuropathol       Date:  2001-06       Impact factor: 17.088

6.  Infiltrating cells, related cytokines and chemokine receptors in lesional skin of patients with dermatomyositis.

Authors:  M Caproni; D Torchia; C Cardinali; W Volpi; E Del Bianco; A D'Agata; P Fabbri
Journal:  Br J Dermatol       Date:  2004-10       Impact factor: 9.302

7.  Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: Interaction with chemokines and Th1 cytokine-producing cells.

Authors:  Guillaume Page; Guillaume Chevrel; Pierre Miossec
Journal:  Arthritis Rheum       Date:  2004-01

8.  Microvascular deposition of complement membrane attack complex in dermatomyositis.

Authors:  J T Kissel; J R Mendell; K W Rammohan
Journal:  N Engl J Med       Date:  1986-02-06       Impact factor: 91.245

Review 9.  Cytokines, chemokines, and cell adhesion molecules in inflammatory myopathies.

Authors:  Dominique Figarella-Branger; Muriel Civatte; Catherine Bartoli; Jean-François Pellissier
Journal:  Muscle Nerve       Date:  2003-12       Impact factor: 3.217

10.  Fas engagement induces the maturation of dendritic cells (DCs), the release of interleukin (IL)-1beta, and the production of interferon gamma in the absence of IL-12 during DC-T cell cognate interaction: a new role for Fas ligand in inflammatory responses.

Authors:  M Rescigno; V Piguet; B Valzasina; S Lens; R Zubler; L French; V Kindler; J Tschopp; P Ricciardi-Castagnoli
Journal:  J Exp Med       Date:  2000-12-04       Impact factor: 14.307

View more
  16 in total

1.  Embryonic stem cell-derived exosomes inhibit doxorubicin-induced TLR4-NLRP3-mediated cell death-pyroptosis.

Authors:  Zahra Tavakoli Dargani; Dinender K Singla
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-06-07       Impact factor: 4.733

2.  Quantitative T cell subsets profile in peripheral blood from patients with idiopathic inflammatory myopathies: tilting the balance towards proinflammatory and pro-apoptotic subsets.

Authors:  F Espinosa-Ortega; D Gómez-Martin; K Santana-De Anda; J Romo-Tena; P Villaseñor-Ovies; J Alcocer-Varela
Journal:  Clin Exp Immunol       Date:  2015-03       Impact factor: 4.330

3.  Overexpression of IL-32alpha increases natural killer cell-mediated killing through up-regulation of Fas and UL16-binding protein 2 (ULBP2) expression in human chronic myeloid leukemia cells.

Authors:  Soyoung Cheon; Ji Hyung Lee; Sunyoung Park; Sa Ik Bang; Wang Jae Lee; Do-Young Yoon; Sung-Soo Yoon; Taesung Kim; Hyeyoung Min; Byung Joo Cho; Hyong Joo Lee; Ki Woong Lee; Seung Hwan Jeong; Hyunjeong Park; Daeho Cho
Journal:  J Biol Chem       Date:  2011-02-14       Impact factor: 5.157

Review 4.  Interleukin-17 in inflammatory myopathies.

Authors:  Anne Tournadre; Pierre Miossec
Journal:  Curr Rheumatol Rep       Date:  2012-06       Impact factor: 4.592

5.  Exosomes derived from cardiac parasympathetic ganglionic neurons inhibit apoptosis in hyperglycemic cardiomyoblasts.

Authors:  Reetish Singla; Kaley H Garner; Mohtashem Samsam; Zixi Cheng; Dinender K Singla
Journal:  Mol Cell Biochem       Date:  2019-08-29       Impact factor: 3.396

Review 6.  The tumor necrosis factor superfamily of cytokines in the inflammatory myopathies: potential targets for therapy.

Authors:  Boel De Paepe; Kim K Creus; Jan L De Bleecker
Journal:  Clin Dev Immunol       Date:  2011-10-23

7.  TNF-Alpha in the Locomotor System beyond Joints: High Degree of Involvement in Myositis in a Rabbit Model.

Authors:  Sture Forsgren; Lina Renström; Craig Purdam; James E Gaida
Journal:  Int J Rheumatol       Date:  2012-03-07

8.  Bilateral muscle fiber and nerve influences by TNF-alpha in response to unilateral muscle overuse - studies on TNF receptor expressions.

Authors:  Lina Renström; Per Stål; Yafeng Song; Sture Forsgren
Journal:  BMC Musculoskelet Disord       Date:  2017-11-28       Impact factor: 2.362

Review 9.  Macrophages and Stem Cells-Two to Tango for Tissue Repair?

Authors:  Emilia Manole; Cristina Niculite; Ioana Maria Lambrescu; Gisela Gaina; Octavian Ioghen; Laura Cristina Ceafalan; Mihail Eugen Hinescu
Journal:  Biomolecules       Date:  2021-05-06

Review 10.  Cytokines and chemokines as regulators of skeletal muscle inflammation: presenting the case of Duchenne muscular dystrophy.

Authors:  Boel De Paepe; Jan L De Bleecker
Journal:  Mediators Inflamm       Date:  2013-11-05       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.